Yescarta (Axicabtagene Ciloleucel)

Yescarta (axicabtagene ciloleucel) is an autologous chimeric antigen receptor (CAR) T-cell therapy. It is produced by adapting the patient’s own immune cells to recognize and attack specifically targeted cancer cells. Yescarta is FDA-approved to treat adult patients...